|
VASH2 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.838000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.380400E-01 |
| Normal-vs-Stage2 |
8.931700E-02 |
| Normal-vs-Stage3 |
4.145400E-01 |
| Normal-vs-Stage4 |
1.420190E-01 |
| Stage1-vs-Stage2 |
7.087700E-02 |
| Stage1-vs-Stage3 |
2.680000E-01 |
| Stage1-vs-Stage4 |
1.019370E-01 |
| Stage2-vs-Stage3 |
4.836200E-02 |
| Stage2-vs-Stage4 |
1.912090E-02 |
| Stage3-vs-Stage4 |
3.639000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.259000E-01 |
| Normal-vs-AfricanAmerican |
9.222400E-01 |
| Normal-vs-Asian |
9.471000E-01 |
| Caucasian-vs-AfricanAmerican |
6.082800E-01 |
| Caucasian-vs-Asian |
3.999400E-01 |
| AfricanAmerican-vs-Asian |
9.506800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.716600E-01 |
| Normal-vs-Female |
7.101800E-01 |
| Male-vs-Female |
4.244000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.846800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.620800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.048000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.026800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.838600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.818200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.091600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.999400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.736970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.402000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.179600E-02 |
| Classical-VS-Follicular |
2.76550000000153E-06 |
| Classical-VS-Other |
8.487400E-01 |
| Classical-VS-Normal |
2.977800E-01 |
| Tall-VS-Follicular |
2.771700E-04 |
| Tall-VS-Other |
3.100400E-01 |
| Tall-VS-Normal |
3.465900E-02 |
| Follicular-VS-Other |
1.696250E-01 |
| Follicular-VS-Normal |
7.591900E-04 |
| Other-VS-Normal |
9.044400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.119900E-02 |
| Normal-vs-N1 |
1.697610E-01 |
| N0-vs-N1 |
1.277670E-02 |
|
|
